Pradaxa Is Known To Come With Severe & Fatal Side Effects

by Terry Bryant

Pradaxa is a blood thinner that is used to lower the risk of stroke for people dealing with from non-valvular atrial fibrillation, or AFib. This disorder is an arrhythmia of the heart, and can cause palpitations, fainting and heart failure, so medications used to counteract its fatal complications are popular and used by many. However, Dabigatran, the active ingredient found in Pradaxa, comes with side effects that are dangerous and sometimes fatal.

The Food and Drug Administration has found that Dabigatran can cause excessive bleeding, both internal and external. This is due to the fact that the drug deactivates the enzyme thrombin, which synthesizes the protein, fibrin. When linked together into polymers, fibrin creates a mesh-like lattice that binds blood cells together. This creates the coagulation effect that prevents people from losing too much blood when they are subjected to an injury. Dabigtran short circuits this process, and the result is blood that can’t clot as it should to prevent other complications. This can mean that a relatively minor injury may result in shock, organ failure or even death.

The manufacturer of the medication, Boehringer Ingelheim, has confirmed that 260 people died from complications of using the drug in between March of 2008 and October of 2011.

The medication can be difficult to regulate once it is in the body, and testing for it often produces murky results, so vigilance is needed when monitoring its effects on the body. Frequent nose bleeds and coughing up blood are signs that the drug may be having an adverse effect on the user.

Anyone who has taken Pradaxa and suffered from severe complications should contact a drug injury lawyer as soon as possible to explore their options. A legal expert in the field will work to make sure that their client has an airtight claim against the manufacturer and get the restitution that they deserve.